All Cancer Microbiology articles
-
NewsCancer-fighting bacterial product ‘cocktails’ may offer personalized treatment
Bacteria may be the next frontier in cancer treatment, according to researchers who devised a new approach of creating bacteria-derived mixtures — or cocktails — to help fight bladder cancer. They found that the cocktails significantly boost the immune system’s ability to fight cancer.
-
NewsGut bacteria from amphibians and reptiles achieve complete tumor elimination
Researchers have discovered that the bacterium Ewingella americana, isolated from the intestines of Japanese tree frogs (Dryophytes japonicus), possesses remarkably potent anticancer activity.
-
NewsResearchers see dramatic drop in HIV-infected immune cells in patient after cancer treatment received
Researchers report they may have taken an early step toward a more practical HIV cure. They focused on a patient undergoing cancer treatment and also living with HIV, who after receiving chemotherapy, had a significant reduction in the number of CD4+ T immune cells that contained an HIV provirus.
-
NewsEngineering oncolytic bacteria as precision cancer therapeutics
A new review summarizes recent advances in the design and application of synthetic biological strategies that enhance bacterial precision, safety, and efficacy in tumor therapy.
-
NewsGlobal Virus Network announces appointment of new board members
The Global Virus Network (GVN), a worldwide coalition of leading human and animal virologists, has announced the appointment of eight distinguished leaders to its Board of Directors.
-
NewsEngineered virus boosts immune response against glioblastoma in preclinical models
Researchers have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells. A single dose of the modified virus increased T-cell, natural killer cell, and myeloid cell responses in the tumor microenvironment and increased the overall survival in preclinical models.
-
NewsChemists synthesize a fungal compound that holds promise for treating brain cancer
For the first time, chemists have synthesized a fungal compound known as verticillin A, which was discovered more than 50 years ago and has shown potential as an anticancer agent.
-
NewsMental health conditions may heighten liver cancer risk in veterans due to increased hepatitis C
Mental health conditions, especially alcohol use disorder and post-traumatic stress disorder (PTSD), significantly increase the likelihood of developing liver cancer among U.S. veterans living with cirrhosis of any cause.
-
NewsStudy shows common childhood virus can drive bladder cancer development
Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research. The study suggests that a virus most people pick up in childhood can trigger the type of DNA damage that can lead to bladder cancer later in life.
-
NewsLight-sensitive microbial protein may herald new cancer therapies
Researchers used a mouse cancer model to show that tumors expressing Archaerhodopsin 3 shrink after exposure to green light.
-
NewsStudy unravels the fungi-cancer connection
A growing body of evidence indicates that the microbiome within the gut and tumors significantly influences cancer initiation, progression, and treatment response. Current research primarily focuses on bacteria, whilst the role of fungi is only now gaining attention.
-
NewsMucosal virome and host transcriptome interactions reveal viral influence in colorectal polyp development
A new study has provided the first integrated mucosal virome-transcriptome landscape of colorectal polyps, the precursors of colorectal cancer, offering new insights into viral-host interactions at this early disease stage.
-
NewsGut microbiome connects obesity to cancer, impacting public health
A new review highlights growing scientific evidence that imbalances in gut bacteria can influence metabolism, trigger inflammation, and increase cancer risk. These insights offer new possibilities for disease prevention, early detection, and personalized health care.
-
NewsCircadian rhythms as a modulator of gut microbiota-tumor microenvironment crosstalk
A new review examines how circadian disruption modifies the diversity and metabolic functions of gut microbiota, resulting in alterations of microbial metabolites, including short-chain fatty acids and secondary bile acids.
-
NewsNatural, non-engineered bacterium selectively targets colorectal cancer
Scientists have demonstrated that the marine bacterium Photobacterium angustum exhibits potent antitumor effects against colorectal cancer. The natural bacterium requires no genetic modification yet selectively accumulates in tumor tissues with minimal impact on healthy organs.
-
NewsNew research confirms HPV vaccination prevents cervical cancer
Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.
-
NewsProbiotic bifidobacterium may boost cancer treatment and suppress tumors
A new review explores how bifidobacterium, a common probiotic found in the gut, may contribute to cancer prevention and therapy. The authors highlight the growing importance of gut health in cancer treatment and shed light on how bifidobacterium could complement standard cancer therapies.
-
NewsGut bacterium impairs liver cancer treatment, inducing immunotherapy resistance
Researchers discovered that transplanting the gut bacterium Phocaeicola vulgatus into mouse models of liver cancer induced immunotherapy resistance. The finding is consistent with clinical observations in patients, showing that patients with low levels of P. vulgatus responded better to treatment.
-
NewsTraces of bacteria inside brain tumors may affect tumor behavior
Scientists have uncovered unexpected traces of bacteria within brain tumors. This discovery offers new insights into the environment in which brain tumors grow and sets the stage for future studies seeking to improve treatment outcomes.
-
NewsNew bioelectroceutical platform triggers dual cell death, reverses immunosuppression in colorectal cancer
Scientists have developed a new “microbial fuel cell” platform that integrates electrogenic bacteria with piezoelectric nanoparticles to cooperatively eradicate colorectal tumors, reverse immunosuppression, and remodel the gut microbiome.